ATM and malignant colon neoplasm: To examine the efficacy of anti-Gal-9 therapy in ATM-silenced tumors, we first established an ATM knockdown (KD) cancer cell line by transducing the murine CT26 colon cancer cells with lentiviruses encoding shRNA for ATM.